Global perspectives on smallpox vaccine against monkeypox: a comprehensive meta-analysis and systematic review of effectiveness, protection, safety and cross …
H Liu, W Wang, Y Zhang, F Wang, J Duan… - Emerging Microbes & …, 2024 - Taylor & Francis
ABSTRACT A large outbreak of monkeypox occurred in 2022, and most people lack
immunity to orthopoxvirus. Smallpox vaccination is essential for preventing further smallpox …
immunity to orthopoxvirus. Smallpox vaccination is essential for preventing further smallpox …
Monkeypox: A comprehensive review on mutation, transmission, pathophysiology, and therapeutics
S Dutta, R Ghosh, I Dasgupta, P Sikdar, P Santra… - International …, 2025 - Elsevier
Monkeypox virus (MPXV) is the causative agent of the monkeypox (Mpox) disease, belongs
to the Orthopoxvirus genus of the Poxviridae family. Due to the recent re-emergence of Mpox …
to the Orthopoxvirus genus of the Poxviridae family. Due to the recent re-emergence of Mpox …
[HTML][HTML] Enhanced immune responses in mice by combining the mpox virus B6R-protein and aluminum hydroxide-CpG vaccine adjuvants
J Li, X Li, J Dong, J Wei, X Guo, G Wang, M Xu, A Zhao - Vaccines, 2024 - mdpi.com
Novel adjuvants and innovative combinations of adjuvants (Adjuvant Systems) have
facilitated the development of enhanced and new vaccines against re-emerging and …
facilitated the development of enhanced and new vaccines against re-emerging and …
Characterizing the acute antibody response of monkeypox and MVA‐BN vaccine following an Australian outbreak
W Asquith, L Hueston, D Dwyer, J Kok… - Journal of Medical …, 2024 - Wiley Online Library
In response to the emergence of the monkeypox virus (MPXV) in Australia in May 2022, we
developed and evaluated indirect immunofluorescence assays (IFA) for MPXV and Vaccinia …
developed and evaluated indirect immunofluorescence assays (IFA) for MPXV and Vaccinia …
Mpox in people with HIV: A narrative review
H Nakamura, K Yamamoto - HIV medicine, 2024 - Wiley Online Library
Objective The 2022 global mpox outbreak disproportionately impacted people living with
HIV. This review explores recent evidence on mpox in this group, focusing on clinical …
HIV. This review explores recent evidence on mpox in this group, focusing on clinical …
A case of breakthrough mpox infection in an individual non-responder to MVA-BN vaccination
M Bottanelli, E Messina, AR Raccagni… - The Lancet Infectious …, 2024 - thelancet.com
In a recentstudy in The Lancet Infectious Diseases, Nicolò Moschetta and colleagues
compared the neutralising antibody response of individuals at 6 months after mpox (formerly …
compared the neutralising antibody response of individuals at 6 months after mpox (formerly …
Surge of Mpox Cases in Lombardy Region, Italy, October 2023—January 2024
D Moschese, AR Raccagni, A Giacomelli… - Clinical Infectious …, 2024 - academic.oup.com
General Hospital, Legnano, Italy; 14Laboratory of Clinical Microbiology, Virology and
Bioemergencies, Luigi Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy.; 15 …
Bioemergencies, Luigi Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy.; 15 …
The impact of antigenic distance on Orthopoxvirus Vaccination and Mpox Infection for cross-protective immunity
Immunological memory mediates rapid protection following infection or vaccination
including heterologous exposure. However, cross-reactive memory responses in humans …
including heterologous exposure. However, cross-reactive memory responses in humans …
MVA-based SARS-CoV-2 vaccine candidates encoding different spike protein conformations induce distinct early transcriptional responses which may impact …
I Grewe, M Friedrich, ML Dieck, M Spohn… - Frontiers in …, 2024 - frontiersin.org
Introduction Vaccine platforms such as viral vectors and mRNA can accelerate vaccine
development in response to newly emerging pathogens, as demonstrated during the COVID …
development in response to newly emerging pathogens, as demonstrated during the COVID …
Monkeypox 2024 outbreak: Fifty essential questions and answers
As the world still vividly recalls the previous monkeypox (mpox) outbreak that impacted over
120 countries worldwide with more than 99,000 cases in 2022, we are now facing a second …
120 countries worldwide with more than 99,000 cases in 2022, we are now facing a second …